<DOC>
	<DOCNO>NCT02701036</DOCNO>
	<brief_summary>The key goal SPORTAX-NHS compare phenotype multiple system atrophy cerebellar type ( MSA-C ) sporadic adult onset ataxia unknown aetiology ( SAOA ) determine rate disease progression group include determination factor predict development MSA-C vs. SAOA , time onset ataxia , reliable distinction disorder possible . The plan study also allow collect blood sample biomaterials patient sporadic ataxia , useful future genetic biomarker study .</brief_summary>
	<brief_title>Sporadic Degenerative Ataxia With Adult Onset : Natural History Study</brief_title>
	<detailed_description>Progressive ataxia frequently start adult without familial background . These patient may suffer acquire ataxia genetically determine ataxia despite negative family history . In majority , however , genetic acquire cause ataxia identify suggest sporadic degenerative ataxia . They subdivide two group . In one group , underlie brain disease multiple system atrophy ( MSA ) , specifically MSA cerebellar type ( MSA-C ) . The characteristic clinical feature MSA presence severe autonomic failure define orthostatic hypotension urinary incontinence . The second group distinguish MSA-C last absence severe autonomic failure . These patient designate sporadic adult onset ataxia unknown aetiology ( SAOA ) . In first year ataxia onset , distinction MSA-C SAOA often possible . There study compare phenotype MSA-C SAOA , longitudinal study focus evolution phenotype disorder completely lack . In particular , progression rate SAOA compare MSA-C define . In addition , unknown factor predict development MSA-C vs. SAOA , time onset ataxia , reliable distinction disorder possible . To answer question , plan create European registry patient sporadic degenerative ataxia adult onset perform natural history study . The plan study also allow collect blood sample biomaterials patient sporadic ataxia , useful future genetic biomarker study .</detailed_description>
	<mesh_term>Ataxia</mesh_term>
	<mesh_term>Cerebellar Ataxia</mesh_term>
	<criteria>Progressive ataxia Disease onset age 40 year Informative negative family history ( similar disorder first seconddegree relative ; parent older 50 year , , alive , age death 50 year , consanguinity parent ) No establish acquire cause ataxia Clinical exclusion criterion : No onset ataxia association stroke , encephalitis , sepsis , hyperthermia heat stroke ; chronic diarrhea ; unexplained visual loss ; alcohol abuse ; chronic intake anticonvulsant drug ; toxic cause ; malignancy ; rapid progression ( development severe ataxia less 12 week ) ; insulindependent diabetes mellitus Imaging exclusion criterion : No evidence multiple sclerosis , ischemia , hemorrhage tumor posterior fossa ; absence signal abnormality T2/FLAIRimages except abnormality compatible MSA Laboratory exclusion criterion : Negative molecular genetic test FRDA ( require cerebellar atrophy MRI , SCA1 , SCA2 , SCA3 , SCA6 , FMR1 premutation ( require prominent tremor , cognitive impairment signal abnormality T2/FLAIR image middle cerebellar peduncle ) ; antineuronal antibody negative ( require , disease duration less 3 year ) ; normal level vitamin B12 ; VDRL negative ; normal thyreoid function</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>sporadic ataxia</keyword>
	<keyword>MSAc</keyword>
	<keyword>SAOA</keyword>
	<keyword>multiple system atrophy cerebellar type</keyword>
	<keyword>natural history</keyword>
</DOC>